BR9607169A - Use of meletonin and pharmaceutical formulation for use in the treatment of a multiple drug addict - Google Patents

Use of meletonin and pharmaceutical formulation for use in the treatment of a multiple drug addict

Info

Publication number: BR9607169A
Authority: BR; Brazil
Prior art keywords: meletonin; treatment; pharmaceutical formulation; multiple drug; drug addict
Prior art date: 1995-02-01

Application number

BR9607169A

Other languages

Portuguese (pt)

Inventor

Nava Zisapel

Original Assignee

Neurim Pharma 1991

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-01

Filing date

1996-01-29

Publication date

1997-11-11

1995-02-01 Priority claimed from US08/381,535 external-priority patent/US6469044B1/en

1996-01-29 Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991

1997-11-11 Publication of BR9607169A publication Critical patent/BR9607169A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Addiction (AREA)
Psychiatry (AREA)
Toxicology (AREA)
Anesthesiology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

BR9607169A 1995-02-01 1996-01-29 Use of meletonin and pharmaceutical formulation for use in the treatment of a multiple drug addict BR9607169A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/381,535 US6469044B1 (en)	1995-02-01	1995-02-01	Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en)	1995-02-01	1995-06-06	Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en)	1995-02-01	1996-01-29	Use of melatonin for treating patients suffering from drug addiction

Publications (1)

Publication Number	Publication Date
BR9607169A true BR9607169A (en)	1997-11-11

Family

ID=26140195

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9607169A BR9607169A (en)	1995-02-01	1996-01-29	Use of meletonin and pharmaceutical formulation for use in the treatment of a multiple drug addict

Country Status (22)

Country	Link
JP (1)	JP4516159B2 (en)
CN (1)	CN1083263C (en)
AT (1)	AT408188B (en)
AU (1)	AU695366B2 (en)
BG (1)	BG62876B1 (en)
BR (1)	BR9607169A (en)
CZ (1)	CZ291349B6 (en)
DK (1)	DK176081B1 (en)
EE (1)	EE03384B1 (en)
FI (1)	FI119586B (en)
IS (1)	IS1980B (en)
LU (1)	LU90118B1 (en)
LV (1)	LV11940B (en)
MD (1)	MD1716C2 (en)
NO (1)	NO312814B1 (en)
NZ (1)	NZ298878A (en)
PL (1)	PL183148B1 (en)
SI (1)	SI9620022A (en)
SK (1)	SK284521B6 (en)
TR (1)	TR199700723T1 (en)
TW (1)	TW483757B (en)
WO (1)	WO1996023496A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU782266B2 (en)	2000-01-05	2005-07-14	Neurim Pharmaceuticals (1991) Ltd.	Method and formulation for treating resistance to antihypertensives and related conditions
IL149377A (en) *	2002-04-28	2012-10-31	Neurim Pharma 1991	Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL155666A (en)	2003-04-29	2013-12-31	Neurim Pharma 1991	Composition for treating insomnia
US9119846B2 (en)	2003-04-29	2015-09-01	Neurim Pharmaceuticals (1991) Ltd.	Method and composition for enhancing cognition in alzheimer's patients
US8785492B2 (en)	2012-01-26	2014-07-22	Vanda Pharmaceuticals Inc.	Treatment of circadian rhythm disorders
US11918557B2 (en)	2012-01-26	2024-03-05	Vanda Pharmaceuticals Inc.	Treatment of circadian rhythm disorders
AU2013361459A1 (en)	2012-12-18	2015-07-02	Vanda Pharmaceuticals Inc.	Treatment of circadian rhythm disorders
US10376487B2 (en)	2013-11-12	2019-08-13	Vanda Pharmaceuticals Inc.	Method of treatment
US11090285B2 (en)	2013-11-12	2021-08-17	Vanda Pharmaceuticals Inc	Treatment of circadian rhythm disorders
RS61024B1 (en) *	2016-10-31	2020-12-31	Neurim Pharma 1991	Melatonin mini-tablets and method of manufacturing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2134789T3 (en) *	1991-05-09	1999-10-16	Neurim Pharma 1991	COMPOSITIONS CONTAINING MELATONIN.
IT1251544B (en) *	1991-05-13	1995-05-17	Gabriele Biella	PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE

1996
- 1996-01-29 AU AU44574/96A patent/AU695366B2/en not_active Expired
- 1996-01-29 CN CN96191750A patent/CN1083263C/en not_active Expired - Lifetime
- 1996-01-29 WO PCT/IB1996/000082 patent/WO1996023496A1/en not_active Ceased
- 1996-01-29 SK SK1030-97A patent/SK284521B6/en unknown
- 1996-01-29 JP JP52338596A patent/JP4516159B2/en not_active Expired - Lifetime
- 1996-01-29 EE EE9700166A patent/EE03384B1/en not_active IP Right Cessation
- 1996-01-29 CZ CZ19972405A patent/CZ291349B6/en not_active IP Right Cessation
- 1996-01-29 BR BR9607169A patent/BR9607169A/en not_active Application Discontinuation
- 1996-01-29 TR TR97/00723T patent/TR199700723T1/en unknown
- 1996-01-29 NZ NZ298878A patent/NZ298878A/en not_active IP Right Cessation
- 1996-01-29 AT AT0901396A patent/AT408188B/en not_active IP Right Cessation
- 1996-01-29 PL PL96321630A patent/PL183148B1/en unknown
- 1996-01-29 SI SI9620022A patent/SI9620022A/en not_active IP Right Cessation
- 1996-01-29 MD MD97-0254A patent/MD1716C2/en not_active IP Right Cessation
- 1996-04-12 TW TW085104319A patent/TW483757B/en not_active IP Right Cessation
1997
- 1997-07-24 LV LVP-97-144A patent/LV11940B/en unknown
- 1997-07-25 IS IS4532A patent/IS1980B/en unknown
- 1997-07-30 BG BG101803A patent/BG62876B1/en unknown
- 1997-07-30 DK DK199700896A patent/DK176081B1/en not_active IP Right Cessation
- 1997-07-31 NO NO19973531A patent/NO312814B1/en not_active IP Right Cessation
- 1997-07-31 FI FI973185A patent/FI119586B/en not_active IP Right Cessation
- 1997-08-01 LU LU90118A patent/LU90118B1/en active

Also Published As

Publication number	Publication date
DK89697A (en)	1997-07-30
NO973531D0 (en)	1997-07-31
WO1996023496A1 (en)	1996-08-08
FI973185A0 (en)	1997-07-31
BG101803A (en)	1998-04-30
SK284521B6 (en)	2005-05-05
LV11940A (en)	1998-01-20
TR199700723T1 (en)	1998-02-21
LU90118B1 (en)	1997-11-13
JP4516159B2 (en)	2010-08-04
NO973531L (en)	1997-09-30
AU4457496A (en)	1996-08-21
ATA901396A (en)	2001-02-15
PL321630A1 (en)	1997-12-08
NZ298878A (en)	1999-05-28
PL183148B1 (en)	2002-05-31
LV11940B (en)	1998-05-20
JPH10513177A (en)	1998-12-15
MD970254A (en)	1999-05-31
DK176081B1 (en)	2006-04-18
CZ291349B6 (en)	2003-02-12
IS1980B (en)	2005-01-14
MX9705856A (en)	1998-07-31
FI119586B (en)	2009-01-15
FI973185L (en)	1997-09-30
BG62876B1 (en)	2000-10-31
AU695366B2 (en)	1998-08-13
EE9700166A (en)	1998-02-16
CZ240597A3 (en)	1998-01-14
TW483757B (en)	2002-04-21
SI9620022A (en)	1998-10-31
MD1716B2 (en)	2001-08-31
IS4532A (en)	1997-07-25
NO312814B1 (en)	2002-07-08
EE03384B1 (en)	2001-04-16
MD1716C2 (en)	2002-02-28
AT408188B (en)	2001-09-25
CN1083263C (en)	2002-04-24
CN1172431A (en)	1998-02-04
SK103097A3 (en)	1998-01-14

Similar Documents

Publication	Publication Date	Title
BR9510510A (en)	1998-07-07	Pharmaceutical aerosol formulation using it and processes for manufacturing it to treat a patient in need of therapy
BR9610248A (en)	1999-07-06	Compound pharmaceutical composition processes for the treatment of pain and for the preparation of a compound and use of the compound
PT1037667E (en)	2004-08-31	PHARMACEUTICAL FORMULATIONS IN HIDROGEL DEVICES AND METHODS FOR ADMINISTRATION OF DRUGS
FI964028L (en)	1996-10-08	New pharmaceutical formulation and method
BR9510422A (en)	1998-07-07	Powder formulation for administration of medically useful polypeptides use of powder and processes for manufacturing the formulation and for treating a patient in need of therapy
DE69525148D1 (en)	2002-03-14	PHARMACEUTICAL FORMULATION
KR950703566A (en)	1995-09-20	Thienodiazepine compound and its pharmaceutical use [THIENODIAZEPINE COMPOUND AND MEDICINAL USE THEREOF]
BR9703624A (en)	1998-09-01	Combination pharmaceutical formulation process for the treatment of depression in an animal use of mirtazapine use of one or more srri's and packaging
BR9602915A (en)	1998-04-22	Medicines use and pharmaceutical formulation
CY2007001I1 (en)	2009-11-04	MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
DE69618587D1 (en)	2002-02-21	CHINAZOLINE AND PHARMACEUTICAL COMPOSITIONS
BR9510501A (en)	1998-01-13	Aerosol formulation using it and processes for manufacturing it and for treating a patient in need of therapy
FI953479A0 (en)	1995-07-18	1-Arylpyrimidine derivatives and their pharmaceutical use
BR9709267A (en)	1999-08-10	Preparation of monoclonal antibody for administration to a human pharmaceutical formulation use of a monoclonal antibody preparation and process for the manufacture of a monoclonal antibody preparation
EE9900075A (en)	1999-10-15	7α- (-aminoalkyl) oestratrienes, process for their preparation, pharmaceutical preparations containing 7α- (-aminoalkyl) oestratrienes and their use in the manufacture of medicaments
DE69622735D1 (en)	2002-09-05	LYOPHILIZED STABLE PHARMACEUTICAL FORMULATION
DE69600065D1 (en)	1997-10-23	Dermatological and / or pharmaceutical preparation, its manufacture and use
BR9510302A (en)	1997-11-11	Controlled-release pharmaceutical dosage form Method for symptomatic treatment of cough Method for preparing a controlled-release pharmaceutical dosage form composition for use in the symptomatic treatment of cough and application of a controlled-release moguistein dosage form
NO961136D0 (en)	1996-03-20	Pharmaceutical formulation basis for nano-suspensions
FI945198L (en)	1994-11-04	Pharmaceutical and other dosage forms
PT1183029E (en)	2005-09-30	PHARMACEUTICAL PREPARATION CONTAINING THE ACTIVE DIAMORPHINE PRINCIPLE AND ITS USE IN A PROCESS FOR THE TREATMENT OF OPIACEAL DEPENDENCE
BR9607851B1 (en)	2009-01-13	combination and pharmaceutical formulation.
ATE288419T1 (en)	2005-02-15	ALPHA-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
EE9600172A (en)	1997-06-16	Purin-6-one derivatives, their preparation method, use in the preparation of medicaments and medicaments
FI971188L (en)	1997-05-20	Therapeutic vitamin-calcium combination in unit dose form in the form of a galenic tablet, method for its preparation and use

Legal Events

Date	Code	Title	Description
2005-06-07	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2007-04-10	B09B	Patent application refused [chapter 9.2 patent gazette]	Free format text: DE ACORDO COM O ART. 37, INDEFIRO O PRESENTE PEDIDO COM BASE NO ART. 229-A DA LEI 10.196 DE 14/02/2001.